Dr. Inderpal Randhawa is a leading specialist with five board certifications in immunology, allergy, pulmonology, pediatrics, and internal medicine. Early in his career, Dr. Randhawa began to question conventional protocols for the treatment of life-threatening food allergies. Distressed by watching parents suffer the loss of their children to fatal allergic reactions, he purposed to find innovative solutions and change the status quo. His early experience desensitizing lung transplant patients to potentially lethal allergies to indispensable anti-rejection drugs, coupled with his collaboration with national allergy and immunology specialists, led him to develop the safe, innovative solutions now offered through TPIRC and the Southern California Food Allergy Institute.
Since 2005, Dr. Randhawa has successfully treated more than 2,000 patients with life-threatening allergies to peanut, tree nuts, milk, egg, wheat, soy, seafood, seeds, and other foods using his unique, research-based Tolerance Induction Program, achieving an unmatched 99% rate of success.
Dr. Randhawa serves as the program director and research coordinator in two fellowship programs at the David Geffen UCLA School of Medicine and UC Irvine — Miller Children’s Hospital. In addition, he practices clinical medicine in pulmonary diseases, immune deficiencies, allergy and transplant medicine. Dr. Randhawa is also the Founder and Medical Director of the Translational Pulmonary and Immunology Research Center (TPIRC).
Dr. Randhawa received his medical degree from Northwestern University’s Feinberg School of Medicine. After completing a combined internal medicine/pediatrics residency, he completed training in Clinical Immunology & Allergy at UCLA and pediatric and adult pulmonology at UC Irvine – Miller Children’s Hospital. Dr. Randhawa has authored over 150 peer reviewed abstracts and research publications and has served as primary investigator in over 25 clinical trials.
He is married with three children.